An accredited Developing
Stage business incubator
uk inspire Send this page | Bookmark | Print |

Business incubator for biotech and medtech startups

 

Asalus Medical Instruments completes 'first-in-man' trial

Surgical specialist Asalus Medical Instruments has completed a trial of its lead product Ultravision which is a "key milestone" towards launching the product.

The Cardiff Medicentre based business, which earlier this week raised £1.25m to get its products ready for market, said the completion of the 'first-in-man' trial for Ultravision along with the funding will enable it to complete product development and apply for regulatory approval to launch the product in 2013.

Ultravision is a surgical smoke clearing system for use in laparoscopic surgery and a study assessed the use of the product in thirty participants undergoing scheduled laparoscopic gallbladder removal at University Hospital Llandough.

Asalus said the results of the trail demonstrated that Ultravision was "effective in maintaining a clear visual field throughout the laparoscopic procedure".

Asalus managing director Dominic Griffiths added: "Maintaining a clear visual field during laparoscopic surgery remains a key unmet surgical need. The clinical trial results demonstrate that Ultravision is a simple yet highly effective means of achieving this.

"The feedback from surgeons has been extremely encouraging. Ultravision will help them undertake complex operations as safely as possible whilst at the same time reducing the long-term exposure of the theatre team to surgical smoke".

Ann Casey, investment executive at Finance Wales, said: "Finance Wales has backed Asalus over four investment rounds and we are pleased Ultravision's clinical trials have been successful. Ultravision is an innovative product with great commercial potential and Asalus has had a clear focus on bringing it to market. 2013 promises to be an exciting year for the company and we look forward to a successful launch."

Asalus completes trial milestone.


Notes to editors

About Cardiff Medicentre

Cardiff Medicentre is a dedicated incubator for biotech and medtech startups. The facility is set in the grounds of the University of Wales Hospital and is a neighbour to Cardiff University’s School of Medicine.

Established in 1992, Cardiff Medicentre is a joint venture between Cardiff Council, Cardiff University, the Welsh Government and Cardiff & Vale University Health Board. It was the first incubator of its kind in the UK and now provides 32 units of high quality office and lab space accommodation ranging from 284 sq ft to 1,045 sq ft. Low-cost desk leasing facilities are also available to encourage entrepreneurs to enter the Cardiff Medicentre community while writing business plans and raising finance.

Tenants at Cardiff Medicentre benefit from specialist support in establishing and growing their businesses. Their aim, and the aim of the Cardiff Medicentre management team, is graduation – the process of tenant businesses outgrowing the incubation facilities and moving into their own follow-on space, or being acquired.

Examples of successful graduate companies

  • Q Chip Ltd (completed $6 million venture capital investment round in 2011)
  • Cardiff Bioanalytical Services Ltd (acquired by LGC Ltd in 2010)
  • Cardiff Research Consortium (acquired by Capita Group plc for £11.6 million in 2009)
  • BioDynamics Research Ltd (acquired by Quotient BioResearch Ltd in 2008)
  • TrichoTech Ltd (acquired by Concateno plc for £11.25 million in 2007)
  • OnExamination Ltd (acquired by BMJ Group in 2007)

Published on Thu, 24th Jan 2013

 
tenants
how to apply
directions

Follow us

  • RSS Feed